You are here

drug pricing

State laws trying to force drug price transparency come up short, study says

State laws trying to force drug price transparency come up short, study says

Fierce Pharma

Flag link:

Pelosi drug plan would save $370B, but could reduce R&D, forecasters say

Pelosi drug plan would save $370B, but could reduce R&D, forecasters say

Biopharma Dive

Flag link:

Merck CEO: When it comes to drug pricing and politics, pharma's in the 'crosshairs'

Merck CEO: When it comes to drug pricing and politics, pharma's in the 'crosshairs'

Fierce Pharma

Flag link:

MSF calls for J&J to cut price of TB medicine

MSF calls for J&J to cut price of TB medicine

Pharmaforum

Medecins Sans Frontieres

Flag link:

Humira, Rituxan top list of U.S. drugs with biggest price increases -report

Humira, Rituxan top list of U.S. drugs with biggest price increases -report

Yahoo/Reuters

Flag link:

Buttigieg unveils an aggressive plan for lowering drug prices

Buttigieg unveils an aggressive plan for lowering drug prices

Stat

2020 Presidential election

Flag link:

Nevada Fines Drugmakers $17M for Failing to Comply With Drug Pricing Law

Nevada Fines Drugmakers $17M for Failing to Comply With Drug Pricing Law

RAPS.org

Flag link:

Aspen admits 1,800% U.K. price hike was wrong—and it'll pay $10M in penance

Aspen admits 1,800% U.K. price hike was wrong—and it'll pay $10M in penance

Fierce Pharma

Flag link:

The Real Impact Of Drug Price Legislation On Biopharmaceutical R & D

The Real Impact Of Drug Price Legislation On Biopharmaceutical R & D

Forbes

Flag link:

Shiny, new and expensive: ESMO studies find new cancer drugs carry higher prices, add little benefit

Shiny, new and expensive: ESMO studies find new cancer drugs carry higher prices, add little benefit

Fierce Pharma

Flag link:

Sanofi, AZ, Lilly and more win business in China's expanded cut-price purchase program

Sanofi, AZ, Lilly and more win business in China's expanded cut-price purchase program

Fierce Pharma

Flag link:

Drug Pricing: Innovation, Investment, and the Public Good

Drug Pricing: Innovation, Investment, and the Public Good

Xconomy

Flag link:

Can Synthetic Biology Make Insulin Faster, Better and Cheaper?

Can Synthetic Biology Make Insulin Faster, Better and Cheaper?

Forbes

Flag link:

The top drugs facing cuts under Pelosi's pricing plan

The top drugs facing cuts under Pelosi's pricing plan

Biopharma Dive

Flag link:

Amid a political firestorm over pharma's pricing, net prices actually fell last quarter: report

Amid a political firestorm over pharma's pricing, net prices actually fell last quarter: report

Fierce Pharma

Flag link:

Regulatory barriers limit state alternative Rx payment models

Regulatory barriers limit state alternative Rx payment models

Healthcare Dive

alternative payments

Flag link:

Price rollbacks, Medicare negotiations, fines and more: Pharma's likely to hate House pricing plan

Price rollbacks, Medicare negotiations, fines and more: Pharma's likely to hate House pricing plan

Fierce Pharma

Flag link:

Employers Slowly Warm to Point-of-Sale Rebates—But Must Move Faster for Insulin

Employers Slowly Warm to Point-of-Sale Rebates—But Must Move Faster for Insulin

Drug Channels

point-of-sale rebates

Flag link:

Half-Off Sale! Five Major Drugmakers Reveal Vast Gross-to-Net Price Gaps—and Why Rebate Reform Is Still Needed

Half-Off Sale! Five Major Drugmakers Reveal Vast Gross-to-Net Price Gaps—and Why Rebate Reform Is Still Needed

Drug Channels

Flag link:

Biden Praises Pharma to Donors as He Pushes to Cut Prices

Biden Praises Pharma to Donors as He Pushes to Cut Prices

Bloomberg

2020 Presidential election

Flag link:

Pages